Does NAD+ injection actually do anything?
For documented clinical NAD+ deficiency or specific neurodegenerative protocols, possibly yes under medical supervision. For general longevity / anti-aging in healthy adults, the human evidence is thin and the bioavailability case is contested. Oral NMN at 250 to 500 mg daily has stronger trial data for raising blood NAD+ than IV / subcutaneous NAD+ does.
Last reviewed · Panya.health editorial
What the bench science actually shows
Intracellular NAD+ does decline with age in most tissues studied. Sinclair, Imai, and others established this through the 2010s. The downstream question is different: does restoring NAD+ via supplementation reverse functional aging endpoints? Support for that claim is weaker. Yoshino 2021 in Science showed NMN raised muscle insulin sensitivity in postmenopausal women. Brakedal 2022 in Cell Metabolism showed nicotinamide riboside in Parkinson's. Both used oral precursors, not IV NAD+. Direct IV / subcutaneous NAD+ pharmacokinetics are messy: most of an injected dose appears to be metabolized to nicotinamide before it reaches cells, then reconstituted intracellularly via the same salvage pathway oral NMN feeds.
When the trade is reasonable
Clinical NAD+ deficiency confirmed by labs (rare). Specific neurodegenerative or post-acute protocols where a clinician is supervising and dose / frequency is medically rationalized. Some addiction-recovery clinics use IV NAD+ at 500 to 1,000 mg over 4 to 10 hours per session for opioid / alcohol withdrawal symptoms; the protocol is real and Mestayer 2018 published case-series data, though placebo-controlled trials remain sparse.
When the trade is bad
General wellness or vague 'I want to feel younger.' Cost is meaningful (subcutaneous injection runs $50 to $150 per session at wellness clinics; IV bag protocols run $500 to $1,500). The bioavailability case for direct NAD+ injection vs oral precursor is contested. If you want to raise blood NAD+ on a research-validated path, NMN oral at 250 to 500 mg daily has stronger pharmacokinetic + small-trial support than injection. Active or recent cancer is a hard contraindication: NAD+ is also fuel for tumor cell metabolism, and SIRT1 activation (the proposed longevity mechanism) cuts both ways depending on the cancer type.
Where Panya stands
NAD+ is documented at panya.health/peptide/nad-plus with the mechanism, evidence (separating oral precursor data from IV NAD+ data explicitly), and risk profile. Panya does NOT yet route to vendors for either oral NMN or injectable NAD+ because non-GLP-1 vendor scoring is gated on lawyer review. Wellness-clinic IV protocols are licensed medical practice in most jurisdictions; that's a separate clinical channel from the research-chem injectable NAD+ vials sold by Telegram resellers.
Read about these peptides
NAD+ is a coenzyme in every living cell, central to energy metabolism and DNA repair. Levels decline with age. Sold as IV infusion (clinic), subcutaneous injection, oral precursors (NMN, NR), and nasal spray. Best-studie...
NMN is an oral nicotinamide-adenine-dinucleotide precursor. Sinclair-popularized longevity intervention with real Phase 2 human-trial data on insulin sensitivity. Different from injectable NAD+ in mechanism, evidence bas...
Related posts
The phrase on every grey-market peptide site. What it actually means, what it does not mean, and why reading it wrong costs people money.
The five things that matter on a COA, the three things that do not, and the one question that separates a serious vendor from a cargo-cult operator.
The clinic route costs more and takes longer. The research-chem route puts more on you. Neither is wrong. Here is how to choose.
People who asked this also asked
The tools behind the answer
The answer for your situation.
The answer above is the general case. The match for your specific profile, region, budget, and urgency comes from our 2-minute quiz. One email, your match, no list.
We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.